Dr Michael Maxwell has over 20 years' experience across a diverse client base in regulatory, dispute resolution and international risk matters. Michael’s legal skills are complemented by his scientific research background in Pharmacology and Toxicology.

Michael's practice encompasses regulatory investigations and defence of prosecutions, corporate governance and sustainability, supply chain obligations, anti-bribery and corruption, sanctions, anti-money laundering, security issues, product liability and health & safety issues.

National and international clients recognise Michael as having outstanding strategic, commercial and technical skills coupled with a strong market profile.

His extensive experience includes a wide range of complex litigious (test case / class actions) and advisory matters on behalf of leading Australian and multi-national companies from agribusiness, mining, oil & gas, pharmaceutical, transport and chemicals industries.

These matters typically required sophisticated analysis of emerging theories of liability, contractual or regulatory obligations and cutting-edge scientific issues, including close collaboration with leading international experts.

Michael has longstanding experience dealing with onerous regulatory environments, including those that impose strict obligations on the international activities of Australian-based companies. Michael has been particularly heavily involved in assisting clients and industry bodies to navigate changing regulatory environments, to defend or manage regulatory investigations and prosecutions, as well as to advocate for improved laws and implementation of those laws.

Michael is a member of the Australian Product Liability Association (APLA), the Defense Research Institute (DRI) (US), the Australian Insurance Law Association (AILA), the Australasian Society of Clinical & Experimental Pharmacologists and Toxicologists (ASCEPT), and the Australasian College of Toxicology & Risk Assessment (ACTRA).